Most Recent
Peak legal body clashes with ACCC on reform to merger regime
The Law Council of Australia has come out in opposition to calls by the competition regulator for major reform to the country's merger regime, saying the evidence did not support "wholesale" changes.
SARB scores partial win on appeal in Melbourne city parking patent case
Technology company SARB has partially succeeded in a challenge to a ruling that it infringed a rival's intellectual property in its development of a parking system used by the City of Melbourne, with an appeals court finding a judge made an error in his reading of the claims of one patent at issue.
Shareholder class action collapses may up litigation risk, dampen plaintiffs’ appetite
The recent dismissal of two shareholder class actions after hard-fought trials is expected to lead to a recalibration of litigation risk and may discourage plaintiff firms and funders from pursuing what might once have been considered slam dunk cases, experts say.
Block Earner needed financial services licence to offer crypto product, court says
Digital currency exchange Block Earner needed a licence to offer its crypto-backed Earner product, a court has found in one of the first decisions on the application of financial services law to crypto investments.
High Court takes up judicial immunity question in case against Family Court judge
The High Court has agreed to step in to hear an appeal of a ruling that put a Federal Circuit and Family Court judge on the hook for a man's false imprisonment.
High Court won’t hear ex-Greenwoods partner’s appeal in Lendlease whistleblower case
A former Greenwoods & Herbert Smith Freehills partner who alleges he was sacked for complaining about Lendlease's "aggressive taxation position" has lost a bid to argue before the High Court that his claims are covered by new whistleblower protections.
Samsung Bioepis sues Janssen Biotech to invalidate Stelara patents
South Korean biosimilars company Samsung Bioepis has sued Johnson & Johnson's Janssen Biotech to invalidate two patents for Crohn's disease drug Stelara, after reaching a licencing agreement over the medicine in the US.
Worley shareholder class action takes another trip to appeals court
It's a case of déjà vu in a class action against engineering services company Worley, with shareholders heading back to the appeals court after losing a second trial in their drawn out fight over disclosure breaches.
3M may face class action over ‘defective’ combat earplugs
US consumer goods giant 3M is facing a possible class action on behalf of members of the Australian Defence Force who allegedly suffered hearing loss from defective combat earplugs.
Charges laid against director of crypto investment firm A One Multi
A director of defunct investment scheme A One Multi, which allegedly raised $25 million in funds, has been charged with nine counts of running a financial services company without a licence.